Bryan Johnson’s Diagnosis: Autoimmune Gastritis

Bryan Johnson, the 48-year-old biohacker and tech entrepreneur famous for his “Project Blueprint” anti-aging regimen, revealed in early July 2026 that he has autoimmune gastritis (AIG) —a rare, currently incurable chronic disease in which the immune system attacks the stomach lining. He described it starkly on social media: “My stomach is eating itself.”

What is autoimmune gastritis?

Autoimmune gastritis (also called autoimmune atrophic gastritis) is a condition where the body’s immune system mistakenly produces antibodies that target and destroy cells in the stomach lining—especially parietal cells that make acid and help absorb vitamin B12. Over time this can lead to:

  • Stomach lining atrophy (thinning and loss of function)
  • Vitamin B12 deficiency and pernicious anemia
  • Increased risk of stomach (gastric) cancer and certain neuroendocrine tumors

It often develops silently, with few or no early symptoms, which is one reason Johnson suspects he’s had it for years despite only being diagnosed in May 2026.

How Johnson found out

Johnson says he was diagnosed in May 2026 after a series of tests, including:

  • Blood work showing autoimmune markers and B12-related issues
  • Endoscopy and multiple biopsies confirming early-stage AIG limited to the stomach lining

He estimates the condition may have been progressing for over 20 years , based on the degree of atrophy seen.

Why this is ironic (and alarming)

Johnson has spent millions—reportedly around $2 million a year —on extreme longevity protocols: strict diet, supplements, sleep optimization, frequent blood tests, and more, all aimed at “defeating death” and reversing aging. Yet he’s now facing a chronic autoimmune disease that mainstream medicine considers incurable , with treatment focused on management rather than cure.

In his own words:

“When AIG is discovered today, standard medical care concedes defeat, stating that nothing can be done except managing the condition…”

What Johnson plans to do

True to his biohacking ethos, Johnson says he won’t just manage AIG—he intends to try to cure it using advanced technology and experimental approaches. He’s framed it as a challenge to the medical status quo:

  • “No should be incurable because no has yet tried to cure it.”
  • He’s positioned his case as a test of whether cutting-edge science can reverse a condition that’s currently deemed untreatable.

How common is AIG?

Johnson has cited that autoimmune gastritis affects roughly 2–5% of people , making it relatively rare but not ultra-rare. It’s more common in:

  • People with other autoimmune conditions
  • Those with a family history of autoimmune disease
  • Certain genetic backgrounds

Key facts at a glance

  • Disease : Autoimmune gastritis (AIG)
  • Mechanism : Immune system attacks stomach lining cells
  • Status : Chronic, currently incurable; managed, not cured
  • Risks : B12 deficiency, anemia, higher stomach cancer risk
  • Johnson’s twist : Diagnosed mid-2026; believes he’s had it for decades; vows to “solve” it rather than accept management-only care

TL;DR: Bryan Johnson has autoimmune gastritis—a rare, incurable disease where the immune system destroys the stomach lining. Despite spending millions on anti-aging, he was diagnosed in May 2026 and now plans to use experimental methods to try to cure it rather than just manage it.

Information gathered from public forums or data available on the internet and portrayed here.